References
- Abiola, T., Udofia, O., Sheikh, T. L., & Sanni, K. (2015). Assessing change readiness and treatment eagerness among psychoactive substance users in northern Nigeria. Journal of Substance Abuse Treatment, 58, 72–77. https://doi.org/10.1016/j.jsat.2015.06.012
- Addiction Policy Forum (2020, May). COVID-19 pandemic impact on patients, families and individuals in recovery from substance use disorder. Addiction Policy Forum. https://www.addictionpolicy.org/post/covid-19-pandemic-impact-on-patients-families-individuals-in-recovery-fromsubstance-use-disorder
- Arya, S., & Gupta, R. (2020). Covid-19 outbreak: Challenges for addiction services in India. Asian Journal of Psychiatry, 51. https://doi.org/http://doi.10.1016/j.ajp.2020.102086
- Atilola, O., Ola, B., & Abiri, G. (2016). Service and policy implication of substance use disorders among adolescents in juvenile correctional facilities in Lagos, Nigeria. Global Mental Health, 3(e30). https://doi.org/10.1017/gmh.2016.25
- Bickel, W. K., Johnson, M. W., Koffarnus, M. N., MacKillop, J., & Murphy, J. G. (2014). The behavioural economics of substance use disorders: Reinforcement pathologies and their repair. Annual Review of Clinical Psychology, 10(1), 641–677. https://doi.org/10.1146/annurev-clinpsy-032813-153724
- Chan, J. F., Yuan, S., Kok, K.-H., To, K. K., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C., Poon, R. W., Tsoi, H.-W., Lo, S. K. F., Chan, K.-H., Poon, V. K. M., Chan, W.-M., Ip, J. D., Cai, J.-P., Cheng, V. C. C., Chen, H., Hui, C. K. M., & Yuen, K.-Y. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. The Lancet, 395(10223), 514–523. https://doi.org/10.1016/S0140-6736(20)30154-9
- Dumbili, E. W. (2020). Cannabis normalization among young adults in a Nigerian city. Journal of Drug Issues, 50(3), 286–302. https://doi.org/10.1177/0022042620912805
- Ebigbo, P. O., Elekwachi, C. L., & Nweze, C. F. (2012). Challenges in the treatment of drug abuse in a Nigerian female health worker: A case study applying the Wawa technique. Journal of Contemporary Psychotherapy, 42(4), 257–264. https://doi.org/10.1007/s10879-012-9213-9
- European Monitoring Centre for Drugs and Drug Addiction. (2020a). Impact of COVID-19 on drug services and help-seeking in Europe. Publications Office of the European Union. https://www.emcdda.europa.eu/system/files/publications/13073/EMCDDA-Trendspotter-Covid-19_Wave-1-2.pdf
- European Monitoring Centre for Drugs and Drug Addiction. (2020b). EMCDDA update on the implications of COVID-19 for people who use drugs and drug service providers, March 2020. EMCDDA. https://www.emcdda.europa.eu/system/files/publications/12879/emcdda-covid-update-1-25.03.2020v2.pdf
- Ezenwa, M., Orjiakor, T., Ukwuma, M., Oraetue, H., Ude, E., & Nweze, T. (2020). Tracking opiate routes in Nigeria: Identifying trafficking routes via dealers and users of tramadol and codeine. Bulletin on Narcotics, LXII, 27–47. https://doi.org/10.17863/CAM.50293
- Ganesh, A., Sahu, P., Nair, S., & Chand, P. (2020). A smartphone based e-Consult in addiction medicine: An initiative in COVID lockdown. Asian Journal of Psychiatry, 51, 102120. https://doi.org/10.1016/j.ajp.2020.102120. Article102120.
- Governors, Board Medical Council of India. (2020). Telemedicine practice guidelines: Enabling registered medical practitioners to provide healthcare using telemedicine. Medical Council of India. https://www.mohfw.gov.in/pdf/Telemedicine.pdf
- Gureje, O., Degenhardt, L., Olley, B., Uwakwe, R., Udofia, O., Wakil, A., & Anthony, J. C. (2007). A descriptive epidemiology of substance use and substance use disorders in nigeria during the early 21st century. Drug and Alcohol Dependence, 91(1), 1–9. https://doi.org/10.1016/j.drugalcdep.2007.04.010
- Hale, T., Webster, S., Petherick, A., Phillips, T., & Kira, B. (2020). Oxford COVID-19 government response tracker. Blavatnik School of Government. https://www.bsg.ox.ac.uk/research/research-projects/oxford-covid-19-government-response-tracker
- Holmes, E. A., O’Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., Christensen, H., Cohen Silver, R., Everall, I., Ford, T., John, A., Kabir, T., King, K., Madan, I., Michie, S., Przybylski, A. K., Shafran, R., Sweeney, A., Worthman, C. M., Bullmore, E., & Ballard, C. (2020). Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science. The Lancet Psychiatry, 7(6), 547–560. https://doi.org/10.1016/S2215-0366(20)30168-1
- Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease- 2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55(3), 105924.
- Lambo, T. A. (1960). Further neuropsychiatric observations in Nigeria. British Medical Journal, 2(5214), 1696–1704. https://doi.org/10.1136/bmj.2.5214.1696
- Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., Tu, W., Feng, Z., & Ren, R. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316
- Marsden, J., Darke, S., Hall, W., Hickman, M., Holmes, J., Humphreys, K., Neale, J., Tucker, J., & West, R. (2020). Mitigating and learning from the impact of COVID‐19 infection on addictive disorders. Addiction, 115(6), 1007–1010. https://doi.org/10.1111/add.15080
- Mehanović, E., Virk, H. K., Akanidomo, I., Pwajok, J., Prichard, G., van der Kreeft, P., & Vigna-Taglianti, F. (2020). Correlates of cannabis and other illicit drugs use among secondary school adolescents in Nigeria. Drug and Alcohol Dependence, 206, 107457. https://doi.org/10.1016/j.drugalcdep.2019.04.028
- Nelson, E. E., & Abikoye, G. E. (2019). Multiple barriers to utilization of drug abuse treatment by female street sex workers in Nigeria. Journal of Psychoactive Drugs, 51(4), 383–390. https://doi.org/10.1080/02791072.2019.1605103
- Nigeria Centre for Disease Control (2020a). First case of coronavirus disease confirmed in Nigeria. https://ncdc.gov.ng/news/227/first-case-of-corona-virus-disease-confirmed-in-nigeria
- Nigeria Centre for Disease Control (2020b). 100 days of Nigeria COVID-19 response. https://ncdc.gov.ng/news/253/100-days-of-nigeria-covid-19-response
- Obot, I. S. (2004). Assessing Nigeria’s drug control policy, 1994-2000. International Journal of Drug Policy, 15(1), 17–26. https://doi.org/10.1016/S0955-3959(03)00110-5
- Office of the Secretary to the Government of the Federation (2020a). Further measures taken by the federal government to prevent the spread of Covid-19 in Nigeria. https://www.osgf.gov.ng/news-media/press-articles/presido/further-measures-taken-federal-government-prevent-spread-covid-19-nigeria
- Office of the Secretary to the Government of the Federation (2020b). Implementation guidelines for containment of Covid-19. https://covid19.ncdc.gov.ng/media/files/IMPLEMENTATION_GUIDELINES_FOR__EASING_LOCKDOWN_-_F1.pdf
- Ong, S. W. X., Tan, Y. K., Chia, P. Y., Lee, T. H., Ng, O. T., Wong, M. S. Y., & Marimuthu, K. (2020). Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from asymptomatic patient. Jama, 323(16), 1610–1612. https://doi.org/10.1001/jama.2020.3227
- Onifade, P. O., Somoye, E. B., Ogunwobi, O. O., Ogunwale, A., Akinhanmi, A. O., & Adamson, T. A. (2011). A descriptive survey of types, spread and characteristics of substance abuse treatment centres in Nigeria. Substance Abuse Treatment, Prevention, and Policy, 6(1), 25. https://doi.org/10.1186/1747-597X-6-25
- Palmer, F., Jaffray, M., Moffat, M. A., Matheson, C., McLernon, D. J., Coutts, A., & Haughney, J. (2012). Prevalence of common chronic respiratory diseases in drug misusers: A cohort study. Primary Care Respiratory Journal, 21(4), 377–383. https://doi.org/10.4104/pcrj.2012.00069
- Scally, G., Jacobson, B., & Abbasi, K. (2020). The UK’s public health response to covid-19. British Medical Journal, 369, m1932. https://doi.org/10.1136/bmj.m1932
- Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., … Pastor Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. British Medical Journal, 357, j1550. https://doi.org/10.1136/bmj.j1550. Articlej.
- State House (2020). President Buhari’s address on the extension of COVID- 19 pandemic lockdown.https://statehouse.gov.ng/news/address-president-buhari-on-the-extension-of-covid-19-pandemic-l0ckdown-at-the-state-house-abuja/
- Substance Abuse and Mental Health Services Administration (2020). Covid-19 and opioid treatment programs. https://www.samhsa.gov/sites/default/files/sample-otp-covid-19-faqs.pdf.
- United Nations Office on Drugs and Crime. (2018). Drug use in Nigeria.
- Vimalananda, V. G., Gupte, G., Seraj, S. M., Orlander, J., Berlowitz, D., Fincke, B. G., & Simon, S. R. (2015). Electronic consultations (e-consults) to improve access to specialty care: A systematic review and narrative synthesis. Journal of Telemedicine and Telecare, 6(21), 323–330.
- Whitefield, M., Reed, H., Webster, J., & Hope, V. (2020). The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England. International Journal of Drug Policy, 102851. https://doi.org/10.1016/j.drugpo.2020.102851
- World Health Organization (2020a, January 28). Clinical management of severe acute respiratory infection when Novel Coronavirus (2019 nCoV) infection is suspected: Interim guidance. https://apps.who.int/iris/handle/10665/330893
- World Health Organization (2020b). Statement on the meeting of the international health regulations (2005). Emergency committee regarding the outbreak of Novel Coronavirus (2019-nCoV). https://www.who.int/news-room/detail/28-01-2020-who-china-leaders-discuss-next-steps-in-battle-against-coronavirus-outbreak
- World Health Organization. (2020c). WHO director-general’s opening remarks at the media briefing on COVID-19, 11 March 2020. https://www.who.int/news-room/detail/13-03-2020-who-un-foundation-and-partners-launch-first-of-its-kind-covid-19-solidarity-response-fund
- World Health Organization. (2020d). Coronavirus disease 2019 (COVID-19)-situation report–157. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200625-covid-19-sitrep-157.pdf?sfvrsn=423f4a82_2
- Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 323(13), 1239–1242. https://doi.org/10.1001/jama.2020.2648
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017